Literature DB >> 7235362

Quantitation and stability of the fifth component of complement (C5) in bronchoalveolar lavage fluids obtained from non-human primates.

W P Kolb, L M Kolb, R A Wetsel, W R Rogers, J O Shaw.   

Abstract

The functional activity and antigenic expression of the fifth component of complement (C5) in concentrated bronchoalveolar lavage fluids (BALF) and serum samples obtained from 13 nonsmoking and 13 smoking baboons was quantified by specific hemolytic titration and radioimmunoassays. The number of C5H505 units per milligram of albumin in BALF obtained from nonsmoking and smoking baboons indicated a nearly 2-fold increase in C5 hemolytic activity in lavage fluids as compared to matched serum samples. No significant differences (p greater than 0.05) in C5 hemolytic or antigenic (radioimmunoassay) expression were evident between BALF samples obtained from nonsmoking and smoking baboons. C5 stability in BALF was indicated by the highly significant correlation (p less than 0.005) between C5 hemolytic activity and antigenic expression. The absence of C5-cleaving enzymes in BALF was verified by incubation of 125I-C5 with these fluids, followed by SDS5 polyacrylamide slab gel and autoradiographic analyses. These results demonstrated the presence and stability of substantial quantities of functionally active C5 in the secretions of primate lungs, which represents a readily available source of phlogistic fragments for the initiation of pulmonary inflammation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7235362     DOI: 10.1164/arrd.1981.123.2.226

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  7 in total

1.  Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways.

Authors:  R C Strunk; D M Eidlen; R J Mason
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

2.  The composition of glycoproteins and activities of glycosidases in bronchoalveolar lavages from smoking baboons.

Authors:  B Radhakrishnamurthy; F Smart; G S Berenson; W R Rogers
Journal:  Lung       Date:  1983       Impact factor: 2.584

Review 3.  B cells and antibodies in the defense against Mycobacterium tuberculosis infection.

Authors:  Jacqueline M Achkar; John Chan; Arturo Casadevall
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

4.  Complement protein C3 binding to Mycobacterium tuberculosis is initiated by the classical pathway in human bronchoalveolar lavage fluid.

Authors:  J Scott Ferguson; Jeremy J Weis; Jennifer L Martin; Larry S Schlesinger
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

5.  Pulmonary response of fifth component of complement-sufficient and -deficient mice to hyperoxia.

Authors:  D A Parrish; B C Mitchell; P M Henson; G L Larsen
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

6.  Impaired lung defenses against Staphylococcus aureus in mice with hereditary deficiency of the fifth component of complement.

Authors:  M C Cerquetti; D O Sordelli; R A Ortegon; J A Bellanti
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

7.  Bifunctional lipocalin ameliorates murine immune complex-induced acute lung injury.

Authors:  Pietro Roversi; Bernhard Ryffel; Dieudonnée Togbe; Isabelle Maillet; Mauro Teixeira; Nurfilza Ahmat; Guido C Paesen; Olga Lissina; Wilhelm Boland; Kerstin Ploss; Joseph J E Caesar; Susanne Leonhartsberger; Susan M Lea; Miles A Nunn
Journal:  J Biol Chem       Date:  2013-04-26       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.